Infanrix Injectable Product
RxNorm 1172748

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1172748 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Infanrix Injectable Product.

The following semantic concepts and normalized strings are associated with this clinical entity:

SBDG
Infanrix Injectable Product
AUI:3838385
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBDGPrescribable

Semantic Branded Dose Form Group (SBDG):
Infanrix Injectable Product
(Atom ID: 3838385)

Clinical Status & Identity

Prescribable Status
YES (Active)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Infanrix Injectable Product
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1172748
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3838385
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBDG
Semantic Branded Dose Form Group (Brand Name + Dose Form Group)
Source Code
1172748
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AVAILABLE STRENGTH
0.05 MG/ML (expressed as Bordetella pertussis filamentous hemagglutinin vaccine, inactivated) / 0.016 MG/ML (expressed as Bordetella pertussis pertactin vaccine, inactivated) / 0.05 MG/ML (expressed as Bordetella pertussis toxoid vaccine, inactivated) / 50 UNT/ML / 20 UNT/ML
Available drug strengths listed in the order of ingredients from the drug